Article
[Research progress in non-small cell lung cancer with concomitant EML4-ALK fusion gene and EGFR gene mutation].
Zhongguo fei ai za zhi = Chinese journal of lung cancer - 1 Nov 2011
Zeng Zhu, Wu Yilong
Abstract excerpt
Lung cancer is one of the most prevalence malignances, of which non-small cell lung cancer (NSCLC) account for 80%-85% of lung cancer. Molecular target therapy is one of the most popular and promising field of NSCLC treatment, and its hotspots includes EGFR (epidermal growth factor receptor), EML4-ALK (echinoderm microtubule associated protein like4-anaplastic lymphoma kinase), etc. Former researches indicated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
